Tumour-infiltrating immune cells, especially tumour-infiltrating lymphocytes (TILs), could play a key role as prognostic indicators in HER2-positive and triple-negative breast cancer (TNBC)4-6. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.